Next, we studied the binding of WT and RPAR-coated CF555-labeled TBSV NPs to cultured NRP-1-positive PPC-1 prostate cancer cells and NRP-1-negative M21 melanoma cells. This evidence concerns the gene NRP1 and prostate carcinoma.